Herceptin subkutan 600mg/5ml, Lösung zur subkutanen Injektion

7680659640012 CH-65964 Lösung
Herceptin subkutan 600mg/5ml, Lösung zur subkutanen Injektion
Herceptin subkutan 600mg/5ml, Lösung zur subkutanen Injektion
Herceptin subkutan 600mg/5ml, Lösung zur subkutanen Injektion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
09/06/2026
Summary of Product Characteristics
Français
09/06/2026
Summary of Product Characteristics
Italien
09/06/2026

Detailed composition

Substance Quantity Type Category
trastuzumabum
600.0 MG Substance Wirkstoff (Principe actif)
hyaluronidasum humanum ADNr
- Substance HNIDK
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
trehalosum dihydricum
- Substance HNIDK
methioninum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 1630.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2017

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
65964
Drug name
Herceptin subkutan, Lösung zur subkutanen Injektion
Galenic form
LSPA
ATC Code
L01FD01
Authorization status
Z
Dispensing category
A
First authorization
24/11/2016
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Mammakarzinom im Frühstadium

Package details

Description (FR)
HERCEPTIN sous-cutané sol inj 600 mg/5 ml flac
Description (DE)
HERCEPTIN subkutan Inj Lös 600 mg/5 ml Durchstf
Market launch
24/11/2016
Narcotic (BTM)
No
Buy us a coffee Explore the data